Lauren Silvernail Net Worth & Insider Trades

Lauren Silvernail - CFO & CBO, Revance Therapeutics, Inc

As of May 24, 2018

What is Lauren Silvernail's Net Worth?

The current estimated net worth of Revance Therapeutics, Inc's CFO & CBO, Lauren Silvernail, is estimated to be about $5.93M . Lauren Silvernail owns about 65,497 units of Revance Therapeutics, Inc common stock. In the last 4 years at Revance Therapeutics, Inc, Lauren Silvernail has sold an estimated value of $2.58M worth.

What is Lauren Silvernail's Past Insider Trading?

Lauren Silvernail's largest purchase order was 25,867 units , worth over $225.04K on March 15, 2018. Lauren Silvernail's largest sale order was 27,019 units , worth over $928.87K on March 15, 2018. In total, Lauren Silvernail has made about 26 transactions over 4 years of their time at Revance Therapeutics, Inc. Lauren Silvernail usually trades in May, with the busiest year in 2017 and 2018. The most recent transaction was a sale order of 2,874 units , worth over $86.92K on May 24, 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Lauren Silvernail's' Mailing Address?

  • Mailing address is 15279 Alton Parkway Suite #100 Irvine CA 92618 CA

Revance Therapeutics, Inc Executive Compensation

Name
Year
Salary
Bonus
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Total
Mark J. Foley 2020 $650,000 - $7,794,350 - $328,331 $8,255 $8,780,936
Mark J. Foley 2019 $189,764 $150,000 $11,728,370 $5,112,573 - $9,723 $17,190,430
Tobin C. Schilke 2020 $421,375 - $1,131,345 $1,273,662 $143,186 $11,531 $2,981,099
Tobin C. Schilke 2019 $407,126 $25,000 $86,150 $299,781 $178,123 $11,078 $1,007,258
Tobin C. Schilke 2018 $64,644 $25,000 $449,280 $1,434,350 - $233 $1,973,507
Abhay Joshi, Ph.D. 2020 $514,608 - $1,405,850 $1,913,759 $213,726 $11,731 $4,059,674
Abhay Joshi, Ph.D. 2019 $485,479 - $271,373 $939,314 $204,211 $9,520 $1,909,897
Abhay Joshi, Ph.D. 2018 $469,062 - $342,513 $1,192,465 $232,186 $9,210 $2,245,436
Dustin Sjuts 2020 $415,000 - $1,294,250 $1,306,320 $141,020 $66,242 $3,222,832
Dustin Sjuts 2019 $378,333 $50,000 $43,075 $99,927 $183,902 $45,786 $801,023
Dwight Moxie 2020 $370,104 $125,000 $1,309,383 $2,579,240 $125,426 $10,356 $4,519,508
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1479290/000147929021000089/rvncfy20proxystatementdef1.htm

What are Revance Therapeutics, Inc's Past Insider Trades?

Revance Therapeutics, Inc's most recent insider trade came on September 16, 2022 by Dwight Moxie who sold 11,000 units worth $297.8K . In the last 8 years, insiders at Revance Therapeutics, Inc have sold an estimated value of $30.1M and bought an estimated value of $8.63M worth of shares. Insider trading is most common in May, with the busiest year in 2021. The most active traders at the company are Daniel Browne, CEO and President,  Curtis Ruegg, EVP,  and Lauren Silvernail, CFO & CBO .

Revance Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1